Related Experiment Videos
Histamine--a major role in allergy?
1University Hospital, Ghent, Belgium.
Summary
Histamine, a key player in allergic reactions, triggers inflammation via H1 receptors. Second-generation antihistamines like ebastine offer effective and well-tolerated relief for seasonal allergic rhinitis without sedation.
Area of Science:
- Immunology
- Pharmacology
Background:
- Histamine is a primary mediator of allergic reactions and inflammation.
- Histamine's proinflammatory actions are mainly mediated by H1 receptors, influencing cytokine release and leukocyte adhesion.
- First-generation antihistamines are effective but cause sedation and side effects due to blood-brain barrier penetration.
Purpose of the Study:
- To evaluate the efficacy and tolerability of ebastine in treating seasonal allergic rhinitis (SAR).
Main Methods:
- Clinical studies assessing ebastine's effectiveness and safety.
- Comparison of ebastine with other antihistamines like azelastine, loratadine, cetirizine, and terfenadine.
Main Results:
- Ebastine (10 mg daily) demonstrated effectiveness, safety, and good tolerability in SAR treatment.
- Ebastine showed a rapid onset of action and comparable symptom relief to other antihistamines.
- No significant side effects were reported with ebastine treatment.
Conclusions:
- Ebastine is a well-tolerated and effective second-generation antihistamine for seasonal allergic rhinitis.
- Ebastine offers a new therapeutic option for SAR due to its potency, selectivity, and improved tolerability profile.